Clinical trial
Evaluation of PD 0348292 for Preventing Blood Clots in the Lungs or Deep Leg…
NCT00306254 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00306254 |
|---|---|
| Title | Evaluation of PD 0348292 for Preventing Blood Clots in the Lungs or Deep Leg Veins of Patients After Knee Surgery |
| Official title | A Phase 2B, Randomized, Multicenter, Dose-Ranging Study Assessing the Safety and Efficacy of PD 0348292 in the Prevention of Venous Thromboembolic Events (VTE) in Subjects Undergoing an Elective, Unilateral Total Knee Replacement |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Venous Thrombosis |
| Intervention type | Drug |
| Interventions | PD 0348292, Enoxaparin |
| Enrollment | 1,225 |
| Start date | Mar 1, 2006 |
| Completion | Jul 1, 2007 |
| First posted | Mar 23, 2006 |
| Last update posted | Oct 10, 2007 |
| Countries | Australia, Canada, Chile, Colombia, Czechia, Denmark, France, Italy, Poland, Portugal, Russia, Slovakia and 4 more |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: